Sign up to save your podcasts
Or
Share Editor's Special Episode: Future Directions in MPN Treatment with Dr. Hobbs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Editor's Special Episode: Future Directions in MPN Treatment with Dr. Hobbs
Dr. Hobbs joins the podcast to discuss the latest advances in myeloproliferative neoplasms (MPNs), including ropeginterferon and the VERIFY trial of rusfertide in polycythemia vera. He highlights key efficacy and safety data, unmet needs in essential thrombocythemia and myelofibrosis, and the next wave of clinical trials to watch.
View all episodes
By Rahul Banerjee, MD
4.8
2727 ratings
Dr. Hobbs joins the podcast to discuss the latest advances in myeloproliferative neoplasms (MPNs), including ropeginterferon and the VERIFY trial of rusfertide in polycythemia vera. He highlights key efficacy and safety data, unmet needs in essential thrombocythemia and myelofibrosis, and the next wave of clinical trials to watch.
More shows like The HemOnc Pulse
View all
JAMA Editors' Summary
136 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
495 Listeners
Hematologic Oncology Update
75 Listeners
Research To Practice | Oncology Videos
118 Listeners
The Hematologist
26 Listeners
Core IM | Internal Medicine Podcast
1,156 Listeners
OncoPharm
187 Listeners
OncLive® On Air
22 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
363 Listeners
Blood Podcast
54 Listeners
Healthcare Unfiltered
136 Listeners
Blood Cancer Talks
48 Listeners
Two Onc Docs
189 Listeners
WolverHeme Happy Hour
30 Listeners